1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. California >
  6. Bausch Health Acquires Obagi

M&A Deal Summary

Bausch Health Acquires Obagi

On March 20, 2013, Bausch Health acquired consumer products company Obagi for 360M USD

Acquisition Highlights
  • This is Bausch Health’s 5th transaction in the Consumer Products sector.
  • This is Bausch Health’s 11th largest (disclosed) transaction.
  • This is Bausch Health’s 11th transaction in the United States.
  • This is Bausch Health’s 4th transaction in California.
Investment Fate
  • Obagi was divested to a consortium of buyers in 2017 for 190M USD.
  • Obagi was sold to a publicly-traded strategic buyer in 2021.

M&A Deal Summary
Date 2013-03-20
Target Obagi
Sector Consumer Products
Buyer(s) Bausch Health
Deal Type Add-on Acquisition
Deal Value 360M USD
Advisor(s) Morgan Stanley (Financial)

Target

Obagi

Long Beach, California, United States
Obagi is a physician-dispensed brand in the dermo-cosmetic space, the highest-growth category in skin care. Obagi's product portfolio includes brands Obagi Nu-Derm®, Condition & Enhance®, Obagi-C® Rx, ELASTIDerm® and CLENZIDerm®.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Bausch Health

Laval, Quebec, Canada
Category Company
Sector Life Science
Employees20,270
Revenue 9.6B USD (2024)
DESCRIPTION

Bausch Health is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology, and branded generics. Bausch Health is based in Laval, Quebec.

DEAL STATS #
Overall 23 of 36
Sector: Consumer Products M&A 5 of 6
Type: Add-on Acquisition M&A Deals 16 of 26
State: California M&A 4 of 7
Country: United States M&A 11 of 23
Year: 2013 M&A 2 of 4
Size (of disclosed) 11 of 28
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-02-01 Natur Produkt

Saint Petersburg, Russia

Natur Produkt provides (OTC) drugs segment in several categories marketed under the umbrella brand, Natur Produkt. Key brands include AntiGrippin, a leading cough and cold remedy, Anti Angin, Sage and Eucaplyptus MA.

Buy $163M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-05-27 Bausch & Lomb

Rochester, New York, United States

Bausch & Lomb is a manufacturer of ophthalmic products.

Buy $8.7B
Mergr

Solution for

Product

Company

Legal